151 related articles for article (PubMed ID: 34985763)
1. The transfusion of non-prophylactically RH-KEL1 antigen-matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients.
Xhaard A; Miekoutima E; Pirenne F; François A; Tiberghien P; Sebert M; Adès L; Fenaux P; Leprêtre AC
Vox Sang; 2022 May; 117(5):693-700. PubMed ID: 34985763
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
Lin Y; Saskin A; Wells RA; Lenis M; Mamedov A; Callum J; Buckstein R
Vox Sang; 2017 Jan; 112(1):79-86. PubMed ID: 28097704
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
Leisch M; Weiss L; Lindlbauer N; Jungbauer C; Egle A; Rohde E; Greil R; Grabmer C; Pleyer L
Leuk Res; 2017 Aug; 59():12-19. PubMed ID: 28535394
[TBL] [Abstract][Full Text] [Related]
5. Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.
Guelsin GA; Rodrigues C; Visentainer JE; De Melo Campos P; Traina F; Gilli SC; Saad ST; Castilho L
Blood Transfus; 2015 Jan; 13(1):53-8. PubMed ID: 24960644
[TBL] [Abstract][Full Text] [Related]
6. Increased Incidence of Red Blood Cell Alloantibodies in Myelodysplastic Syndrome.
Rozovski U; Ben-Tal O; Kirgner I; Mittelman M; Hareuveni M
Isr Med Assoc J; 2015 Oct; 17(10):624-7. PubMed ID: 26665317
[TBL] [Abstract][Full Text] [Related]
7. Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome.
Ortiz S; Orero MT; Javier K; Villegas C; Luna I; Pérez P; Roig M; López M; Costa S; Carbonell F; Collado R; Ivars D; Linares M
Blood Transfus; 2017 Sep; 15(5):472-477. PubMed ID: 27416573
[TBL] [Abstract][Full Text] [Related]
8. Rh antibodies as a result of altered Rh epitopes on transfused red cells: a case series of seven Brazilian patients.
Macedo MD; Miranda MR; Santos TD; Leal I; Castilho L
Blood Transfus; 2021 Sep; 19(5):413-419. PubMed ID: 33085591
[TBL] [Abstract][Full Text] [Related]
9. Donor/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigens.
Xhaard A; Floch A; Ruggiu M; Robin M; Sicre de Fontbrune F; Michonneau D; Kaphan E; Prata PHL; Socié G; Traineau R; Peffault de Latour R; Leprêtre AC
Bone Marrow Transplant; 2024 May; ():. PubMed ID: 38796632
[TBL] [Abstract][Full Text] [Related]
10. Red Blood Cell Alloimmunization in Korean Patients With Myelodysplastic Syndrome and Liver Cirrhosis.
Kim HY; Cho EJ; Chun S; Kim KH; Cho D
Ann Lab Med; 2019 Mar; 39(2):218-222. PubMed ID: 30430787
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
[TBL] [Abstract][Full Text] [Related]
12. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
Waszczuk-Gajda A; Mądry K; Machowicz R; Drozd-Sokołowska J; Stella-Hołowiecka B; Mital A; Obara A; Szmigielska-Kapłon A; Sikorska A; Subocz E; Jędrzejczak WW; Dwilewicz-Trojaczek J
Adv Clin Exp Med; 2016; 25(4):633-41. PubMed ID: 27629836
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study.
Giagounidis A; Mufti GJ; Mittelman M; Sanz G; Platzbecker U; Muus P; Selleslag D; Beyne-Rauzy O; te Boekhorst P; del Cañizo C; Guerci-Bresler A; Nilsson L; Lübbert M; Quesnel B; Ganser A; Bowen D; Schlegelberger B; Göhring G; Fu T; Benettaib B; Hellström-Lindberg E; Fenaux P
Eur J Haematol; 2014 Nov; 93(5):429-38. PubMed ID: 24813620
[TBL] [Abstract][Full Text] [Related]
14. KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study.
Ning S; Morin PA; Elahie A; Li N; Liu Y; Barty R; Clarke G; Zeller M; Heddle NM
Transfusion; 2023 Jan; 63(1):59-68. PubMed ID: 36519693
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell transfusion in myelodysplastic syndromes: A systematic review.
Kaka S; Jahangirnia A; Beauregard N; Davis A; Tinmouth A; Chin-Yee N
Transfus Med; 2022 Feb; 32(1):3-23. PubMed ID: 34927286
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy-related myelodysplastic syndrome.
Adkins BD; Mehta A; Selesky M; Vittitow S; Smolkin ME; Ratcliffe SJ; Luckey CJ
Transfusion; 2022 Dec; 62(12):2470-2479. PubMed ID: 36278434
[TBL] [Abstract][Full Text] [Related]
17. Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions.
Waldis SJ; Uter S; Kavitsky D; Flickinger C; Vege S; Friedman DF; Westhoff CM; Chou ST
Blood Adv; 2021 Feb; 5(3):737-744. PubMed ID: 33560383
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM).
Jouzier C; Cherait A; Cony-Makhoul P; Hamel JF; Veloso M; Thepot S; Cluzeau T; Stamatoullas A; Garnier A; Guerci-Bresler A; Dimicoli-Salazar S; Pica GM; Cheze S; Santana C; Chermat F; Fenaux P; Park S
Transfusion; 2022 May; 62(5):961-973. PubMed ID: 35452143
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.
Shirey RS; Boyd JS; Parwani AV; Tanz WS; Ness PM; King KE
Transfusion; 2002 Nov; 42(11):1435-41. PubMed ID: 12421216
[TBL] [Abstract][Full Text] [Related]
20. [Association of red blood cell and platelet allo-antibodies in platelet alloimmunized patients].
Moncharmont P; Rigal D
Transfus Clin Biol; 2014 Jun; 21(3):99-102. PubMed ID: 24948207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
